Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Retroviral protease inhibiting compounds

Retroviral protease inhibiting compounds

US Patent 6531610 · Granted Mar 11, 2003

Estimated economic value: $245,867,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of filarial diseases2019
Tylosin A analogs and derivatives2018
Macrocyclic hepatitis C serine protease inhibitors2016
Compositions and methods of use of ritonavir for treating HCV2014
Compounds that are useful for improving pharmacokinetics2014
HIV protease inhibiting compounds2014
Macrocyclic hepatitis C serine protease inhibitors2014
Compounds that are useful for improving pharmacokinetics2013
Prodrugs of HIV protease inhibitors2013
Macrocyclic hepatitis C serine protease inhibitors2013
Anti-viral compounds2012
Anti-viral compounds2012